Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	-1.48	-4.6	-3.82	-0.94	-9.02	-1.96
Depreciation & Amortization	4.16	4.04	1.15	0.9	1.77	0.46
Stock-Based Compensation	5.83	5.51	3.17	3.14	4.22	3.38
Other Adjustments	5.09	6.43	1.71	0.2	0.19	-0.4
Change in Receivables	2.99	-6.4	-3.12	-1.56	3.62	-5.42
Changes in Inventories	-4.94	-5.88	-1.84	-0.37	-0.01	0.69
Changes in Accounts Payable	8.61	6.81	2.32	0.05	-0.01	-0.57
Changes in Accrued Expenses	-0.94	3.46	4.72	5.3	2.22	0.12
Changes in Other Operating Activities	-4.09	1.14	-3.31	0.09	1.84	-1.03
Operating Cash Flow	15.84	10.52	0.97	6.82	4.82	-4.72
Operating Cash Flow Growth	186.32%	986.07%	-85.78%	41.36%	-	-
Capital Expenditures	-0.41	-0.33	-0.03	-	-0.04	-0.01
Sale of Property, Plant & Equipment	-	-	-	-	-	0.7
Purchases of Intangible Assets	-15	-	-9.99	-0.78	-2.75	-3.25
Payments for Business Acquisitions	-	-	-30	-	-	-
Investing Cash Flow	-15.41	-0.33	-40.01	-0.78	-2.79	-2.56
Long-Term Debt Issued	-	-	25.31	-	-	-
Long-Term Debt Repaid	-	-	-1.16	-1.16	-0.39	-0.15
Net Long-Term Debt Issued (Repaid)	-	-	24.15	-1.16	-0.39	-0.15
Issuance of Common Stock	1.59	0.82	8.44	0.38	0.25	0.54
Repurchase of Common Stock	-	-	-	-0.18	-	-
Net Common Stock Issued (Repurchased)	1.59	0.82	8.44	0.2	0.25	0.54
Financing Cash Flow	1.81	0.82	32.59	-0.96	-0.13	0.39
Net Cash Flow	2.24	11.01	-6.45	5.08	1.9	-6.89
Free Cash Flow	15.43	10.19	0.94	6.82	4.78	-4.73
Free Cash Flow Growth	51.42%	980.70%	-86.16%	42.48%	-	-
FCF Margin	17.75%	12.75%	2.42%	21.54%	22.51%	-21.67%
Free Cash Flow Per Share	0.53	0.38	0.04	0.27	0.19	-0.19
Levered Free Cash Flow	0.92	4.65	23.34	3.88	-3.63	-2.44
Unlevered Free Cash Flow	4.42	8.4	0.4	4.35	-2.48	-1.83

Updated May 14, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q